Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 2/2019

01-06-2019 | Original Research

Retrospective Assessment of the Diagnostic Accuracy of the Depth of Invasion by Narrow Band Imaging Magnifying Endoscopy in Patients with Superficial Esophageal Squamous Cell Carcinoma

Authors: Chikatoshi Katada, Satoshi Tanabe, Takuya Wada, Kenji Ishido, Takafumi Yano, Yasuaki Furue, Yuki Kondo, Natsuko Kawanishi, Sakiko Yamane, Akinori Watanabe, Mizutomo Azuma, Wasaburo Koizumi

Published in: Journal of Gastrointestinal Cancer | Issue 2/2019

Login to get access

Abstract

Purpose

Treatment strategies for superficial esophageal squamous cell carcinoma (S-ESCC) are determined mainly on the basis of the depth of invasion. We retrospectively studied the accuracy of the depth of tumor invasion, comprehensively assessed using the Japan Esophageal Society (JES) classification.

Methods

The study group comprised 256 patients who underwent narrow band imaging (NBI) magnifying endoscopy, and endoscopic submucosal dissection for S-ESCC. The depth of invasion of S-ESCC was classified into three groups: EP/LPM, MM/SM1, and SM2. The following variables were studied retrospectively: (1) the diagnostic accuracy of non-magnifying white-light endoscopy, (2) the diagnostic accuracy of type B vessels, (3) the diagnostic accuracy of avascular area (AVA), (4) the diagnostic accuracy of the JES classification, and (5) the diagnostic accuracy of comprehensive diagnosis. The depth of invasion was assessed by white-light non-magnifying endoscopy, followed by NBI magnifying endoscopy.

Results

The positive predictive value (PPV) of white-light non-magnifying endoscopy was 86% for EP/LPM, 53% MM/SM1, and 74% for SM2. The PPV of the diagnosis of type B vessels was 93% for EP/LPM, 62% for MM/SM1, and 74% for SM2. The PPV of the AVA diagnosis was 73% for EP/LPM, 89% for MM/SM1, and 100% for SM2. The PPV of diagnosis according to the JES classification was 93% for EP/LPM, 65% for MM/SM1, and 77% for SM2. The PPV of the comprehensive diagnosis was 94% for EP/LPM, 63%, for MM/SM1, and 75% for SM2.

Conclusions

The additional use of NBI magnifying endoscopy can enhance the diagnostic accuracy of the depth of invasion in patients with S-ESCC.
Literature
1.
go back to reference The Japan Esophageal Society. Guidelines for diagnosis and treatment of carcinoma of the esophagus 2017. Tokyo: Kanehara Co Ltd; 2017. (in Japanese) The Japan Esophageal Society. Guidelines for diagnosis and treatment of carcinoma of the esophagus 2017. Tokyo: Kanehara Co Ltd; 2017. (in Japanese)
2.
go back to reference Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of the responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery. 1998;123:432–9.CrossRefPubMed Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of the responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery. 1998;123:432–9.CrossRefPubMed
3.
go back to reference Endo M, Yoshino K, Kawano T, Nagai K, Inoue H. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus. 2000;13:125–9.CrossRefPubMed Endo M, Yoshino K, Kawano T, Nagai K, Inoue H. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus. 2000;13:125–9.CrossRefPubMed
4.
go back to reference Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer. 2002;94:570–5.CrossRefPubMed Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer. 2002;94:570–5.CrossRefPubMed
5.
go back to reference Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome aft er endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc. 2002;56:387–90.CrossRefPubMed Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome aft er endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc. 2002;56:387–90.CrossRefPubMed
6.
go back to reference Ishihara R, Tanaka H, Iishi H, Takeuchi Y, Higashino K, Uedo N, et al. Long-term outcome of esophageal mucosal squamous cell carcinoma without lymphovascular involvement after endoscopic resection. Cancer. 2008;112:2166–72.CrossRefPubMed Ishihara R, Tanaka H, Iishi H, Takeuchi Y, Higashino K, Uedo N, et al. Long-term outcome of esophageal mucosal squamous cell carcinoma without lymphovascular involvement after endoscopic resection. Cancer. 2008;112:2166–72.CrossRefPubMed
7.
go back to reference Fujishiro M, Yahagi N, Kakushima N, Kodashima S, Muraki Y, Ono S, et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol. 2006;4:688–94.CrossRef Fujishiro M, Yahagi N, Kakushima N, Kodashima S, Muraki Y, Ono S, et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol. 2006;4:688–94.CrossRef
8.
go back to reference Takahashi H, Arimura Y, Masao H, Okahara S, Tanuma T, Kodaira J, et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus. Gastrointest Endosc. 2010;72:255–64.CrossRefPubMed Takahashi H, Arimura Y, Masao H, Okahara S, Tanuma T, Kodaira J, et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus. Gastrointest Endosc. 2010;72:255–64.CrossRefPubMed
9.
go back to reference Katada C, Muto M, Momma K, Arima M, Tajiri H, Kanamaru C, et al. Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae—a multicenter retrospective cohort study. Endoscopy. 2007;39:779–83.CrossRefPubMed Katada C, Muto M, Momma K, Arima M, Tajiri H, Kanamaru C, et al. Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae—a multicenter retrospective cohort study. Endoscopy. 2007;39:779–83.CrossRefPubMed
10.
go back to reference Yamashina T, Ishihara R, Nagai K, Matsuura N, Matsui F, Ito T, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol. 2013;108:544–51.CrossRefPubMed Yamashina T, Ishihara R, Nagai K, Matsuura N, Matsui F, Ito T, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol. 2013;108:544–51.CrossRefPubMed
11.
go back to reference Goda K, Tajiri H, Ikegami M, Yoshida Y, Yoshimura N, Kato M, et al. Magnifying endoscopy with narrow band imaging for predicting the invasion depth of superficial esophageal squamous cell carcinoma. Dis Esophagus. 2009;22:453–60.CrossRefPubMed Goda K, Tajiri H, Ikegami M, Yoshida Y, Yoshimura N, Kato M, et al. Magnifying endoscopy with narrow band imaging for predicting the invasion depth of superficial esophageal squamous cell carcinoma. Dis Esophagus. 2009;22:453–60.CrossRefPubMed
12.
go back to reference Inoue H, Honda T, Yoshida T, et al. Ultra-high magnification endoscopy of the normal esophageal mucosa. Dig Endosc. 1996;8:134–8.CrossRef Inoue H, Honda T, Yoshida T, et al. Ultra-high magnification endoscopy of the normal esophageal mucosa. Dig Endosc. 1996;8:134–8.CrossRef
13.
go back to reference Inoue H, Honda T, Nagai K, et al. Ultra-high magnification endoscopic observation of carcinoma in situ of the esophagus. Dig Endosc. 1997;9:16–8.CrossRef Inoue H, Honda T, Nagai K, et al. Ultra-high magnification endoscopic observation of carcinoma in situ of the esophagus. Dig Endosc. 1997;9:16–8.CrossRef
14.
go back to reference Arima M, Tada M, Arima H. Evaluation of microvascular patterns of superficial esophageal cancers by magnifying endoscopy. Esophagus. 2005;2:191–7.CrossRef Arima M, Tada M, Arima H. Evaluation of microvascular patterns of superficial esophageal cancers by magnifying endoscopy. Esophagus. 2005;2:191–7.CrossRef
15.
go back to reference Oyama T, Inoue H, Arima M, Momma K, Omori T, Ishihara R, et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society. Esophagus. 2017;14:105–12.CrossRefPubMed Oyama T, Inoue H, Arima M, Momma K, Omori T, Ishihara R, et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society. Esophagus. 2017;14:105–12.CrossRefPubMed
16.
go back to reference Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, et al. Guidelines for diagnosis and treatment of carcinoma of esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1–30.CrossRef Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, et al. Guidelines for diagnosis and treatment of carcinoma of esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1–30.CrossRef
17.
go back to reference Eguchi T, Nakanishi Y, Shimoda T, Iwasaki M, Igaki H, Tachimori Y, et al. Histopathological criteria for additional treatment aft er endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006;19:475–80.CrossRefPubMed Eguchi T, Nakanishi Y, Shimoda T, Iwasaki M, Igaki H, Tachimori Y, et al. Histopathological criteria for additional treatment aft er endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006;19:475–80.CrossRefPubMed
18.
go back to reference Tajima Y, Yoshimura K, Kusano M, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer. 2000;88:1285–93.CrossRefPubMed Tajima Y, Yoshimura K, Kusano M, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer. 2000;88:1285–93.CrossRefPubMed
19.
go back to reference Kim DU, Lee JH, Min BH, Shim SG, Chang DK, Kim YH, et al. Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma. J Gastroenterol Hepatol. 2008;23:619–25.CrossRefPubMed Kim DU, Lee JH, Min BH, Shim SG, Chang DK, Kim YH, et al. Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma. J Gastroenterol Hepatol. 2008;23:619–25.CrossRefPubMed
20.
go back to reference Ishihara R, Aoi K, Matsuura N, et al. Significance of AVA for prediction of infiltration depth of esophageal cancer. Stomach Intest. 2014;49:204–11. (in Japanese with English abstract) Ishihara R, Aoi K, Matsuura N, et al. Significance of AVA for prediction of infiltration depth of esophageal cancer. Stomach Intest. 2014;49:204–11. (in Japanese with English abstract)
21.
go back to reference Hirasawa D, Fujita N, Maeda Y, et al. Clinical significance of AVA in diagnosing of invasion depth of superficial esophageal cancer. Stomach Intest. 2014;49:196–203. (in Japanese with English abstract) Hirasawa D, Fujita N, Maeda Y, et al. Clinical significance of AVA in diagnosing of invasion depth of superficial esophageal cancer. Stomach Intest. 2014;49:196–203. (in Japanese with English abstract)
22.
go back to reference Kurokawa Y, Muto M, Minashi K, Boku N, Fukuda H. A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan Clinical Oncology Group Study JCOG0508. Jpn J Clin Oncol. 2009;39:686–9.CrossRefPubMedPubMedCentral Kurokawa Y, Muto M, Minashi K, Boku N, Fukuda H. A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan Clinical Oncology Group Study JCOG0508. Jpn J Clin Oncol. 2009;39:686–9.CrossRefPubMedPubMedCentral
23.
go back to reference Muto M, Minashi K, Nihei K et al (2016) Efficacy of combined endoscopic resection and chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma (ESCC): a single-arm confirmatory study (JCOG0508). J Clin Oncol 34 (suppl):abstr 4013. Muto M, Minashi K, Nihei K et al (2016) Efficacy of combined endoscopic resection and chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma (ESCC): a single-arm confirmatory study (JCOG0508). J Clin Oncol 34 (suppl):abstr 4013.
Metadata
Title
Retrospective Assessment of the Diagnostic Accuracy of the Depth of Invasion by Narrow Band Imaging Magnifying Endoscopy in Patients with Superficial Esophageal Squamous Cell Carcinoma
Authors
Chikatoshi Katada
Satoshi Tanabe
Takuya Wada
Kenji Ishido
Takafumi Yano
Yasuaki Furue
Yuki Kondo
Natsuko Kawanishi
Sakiko Yamane
Akinori Watanabe
Mizutomo Azuma
Wasaburo Koizumi
Publication date
01-06-2019
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 2/2019
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-018-0075-6

Other articles of this Issue 2/2019

Journal of Gastrointestinal Cancer 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine